{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:17:08Z","timestamp":1781540228617,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.semarthrit.2016.01.005","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T17:46:44Z","timestamp":1454089604000},"page":"669-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Treatment of tophaceous gout: When medication is not enough"],"prefix":"10.1016","volume":"45","author":[{"given":"Isaac R.","family":"Kasper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Juriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Giurini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Shmerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.01.005_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1477-7525-10-117","article-title":"Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey","volume":"10","author":"Khanna","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.1780270417","article-title":"Tophaceous gout: a clinical and radiographic assessment","volume":"27","author":"Nakayama","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/15257770802136040","article-title":"Asymptomatic hyperuricemia: impact of ultrasonography","volume":"27","author":"Puig","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib4","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/rheumatology\/keg422","article-title":"Trends in the manifestations of gout in Taiwan","volume":"42","author":"Chen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib5","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3483","article-title":"Bone destruction by receptor activator of nuclear factor kappaB ligand-expressing T cells in chronic gouty arthritis","volume":"13","author":"Lee","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrrheum.2011.207","article-title":"Mechanisms of joint damage in gout: evidence from cellular and imaging studies","volume":"8","author":"McQueen","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2106\/00004623-196648020-00001","article-title":"The carpal-tunnel syndrome. Seventeen years\u2019 experience in diagnosis and treatment of six hundred fifty-four hands","volume":"48","author":"Phalen","year":"1966","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3928\/0147-7447-20040801-23","article-title":"Carpal tunnel syndrome due to tophaceous gout","volume":"27","author":"Rich","year":"2004","journal-title":"Orthopedics"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semarthrit.2012.03.007","article-title":"The broad spectrum of urate crystal deposition: unusual presentations of gouty tophi","volume":"42","author":"Forbess","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib12","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.22232","article-title":"Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study","volume":"55","author":"Perez-Ruiz","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib14","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar4318","article-title":"Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy","volume":"15","author":"Baraf","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib15","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar4497","article-title":"Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout","volume":"16","author":"Lipsky","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib16","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/art.23803","article-title":"Treatment-failure gout: a moving target","volume":"58","author":"Edwards","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib17","first-page":"369","article-title":"Treatment failure gout","volume":"92","author":"Ali","year":"2009","journal-title":"Med Health R I"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11926-009-0019-z","article-title":"A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout","volume":"11","author":"Chao","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib19","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar2659","article-title":"Adherence with urate-lowering therapies for the treatment of gout","volume":"11","author":"Harrold","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0049-0172(72)90005-4","article-title":"Surgery for tophaeceous gout","volume":"1","author":"Casangrade","year":"1971","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2106\/00004623-196143050-00010","article-title":"The surgery of gout in the upper extremity","volume":"43","author":"Straub","year":"1961","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2106\/00004623-195840040-00001","article-title":"The surgical management of chronic tophaceous gout","volume":"40A","author":"Larmon","year":"1958","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib23","first-page":"1158","article-title":"A survey of indications, results and complications of surgery for tophaceous gout","volume":"115","author":"Kumar","year":"2002","journal-title":"J N Z Med Assoc"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bjps.2007.12.021","article-title":"Surgical treatment of the chronic tophaceous deformity in upper extremities\u2014the shaving technique","volume":"62","author":"Lee","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.bjps.2013.03.041","article-title":"Timing of intra-lesion shaving for surgical treatment of chronic tophus","volume":"66","author":"Lee","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.arthro.2008.09.002","article-title":"Arthroscopic elimination of monosodium urate deposition of the first metatarsophalangeal joint reduces the recurrence of gout","volume":"25","author":"Wang","year":"2009","journal-title":"Arthroscopy"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/BTH.0b013e3181dcaaa8","article-title":"Different surgical approaches to treat chronic tophaceous gout in the hand: our experience","volume":"14","author":"Tripoli","year":"2010","journal-title":"Tech Hand Up Extrem Surg"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib28","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.3928\/01477447-20140124-15","article-title":"First metatarsophalangeal joint arthrodesis for the treatment of tophaceous gouty arthritis","volume":"37","author":"Kim","year":"2014","journal-title":"Orthopedics"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/ar3489","article-title":"Imaging in gout\u2014what can we learn from MRI, CT, DECT and US?","volume":"13","author":"McQueen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1759720X14542960","article-title":"Imaging in gout: a review of the recent developments","volume":"6","author":"Chowalloor","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1136\/ard.2008.099713","article-title":"Dual energy computed tomography in tophaceous gout","volume":"68","author":"Choi","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib32","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/rheumatology\/kep278","article-title":"An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs","volume":"48","author":"Carter","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib33","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/rheumatology\/kem058","article-title":"Diagnosis of gout by ultrasound","volume":"46","author":"Thiele","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7547\/1020334","article-title":"Surgical treatment of a young patient with bilaterally destroyed first metatarsophalangeal joints suffering from gout","volume":"102","author":"Wunschel","year":"2012","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3113\/FAI.2007.0021","article-title":"Intraosseous gouty tophus of the talus, treated by total curettage and calcium phosphate cement filling: a case report","volume":"28","author":"Morino","year":"2007","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s004029900061","article-title":"Surgical management of tophaceous gout in the hand","volume":"120","author":"Ertugrul Sener","year":"2000","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.semarthrit.2016.01.005_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1460-9584.1999.00152.x","article-title":"Surgical treatment of chronic tophaceous gout arthritis in the feet: a case report","volume":"5","author":"Yetkin","year":"1999","journal-title":"Foot Ankle Surg"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721600041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721600041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T16:31:15Z","timestamp":1600101075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901721600041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S004901721600041X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.01.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of tophaceous gout: When medication is not enough","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}